|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Carteolol#Overdosage]] |
| {{Carteolol}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Overdosage==
| |
| No specific information on emergency treatment of overdosage in humans is available. Should accidental ocular overdosage occur, flush eye(s) with water or normal saline. The most common effects expected with overdosage of a beta-adrenergic blocking agent are bradycardia, bronchospasm, congestive heart failure and hypotension.
| |
| | |
| In case of ingestion, treatment with Ocupress should be discontinued and gastric lavage considered. The patient should be closely observed and vital signs carefully monitored. The prolonged effects of carteolol must be considered when determining the duration of corrective therapy. On the basis of the pharmacologic profile, the following additional measures should be considered as appropriate:
| |
| | |
| '''Symptomatic Sinus Bradycardia or Heart Block''': Administer [[atropine]]. If there is no response to vagal blockade, administer [[isoproterenol]] cautiously.
| |
| | |
| '''Bronchospasm''': Administer a beta2-stimulating agent such as [[isoproterenol]] and/or a theophylline derivative.
| |
| | |
| '''Congestive Heart Failure''': Administer [[diuretics]] and digitalis [[glycoside]]s as necessary.
| |
| | |
| '''Hypotension''': Administer [[vasopressor]]s such as intravenous [[dopamine]], [[epinephrine]] or [[norepinephrine bitartrate]].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ZEBETA (BISOPROLOL FUMARATE) TABLET [DURAMED PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a11548a0-9c0f-4729-907c-75d8f99a6c85 | publisher = | date = | accessdate = 4 February 2014 }}</ref>
| |
| | |
| | |
| | |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Beta blockers]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |